- Home
- Z vs NBIX Comparison
Z vs NBIX Comparison
Compare Z & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- Z
- NBIX
- Stock Information
- Founded
- Z 2004
- NBIX 1992
- Country
- Z United States
- NBIX United States
- Employees
- Z N/A
- NBIX N/A
- Industry
- Z Business Services
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- Z Consumer Discretionary
- NBIX Health Care
- Exchange
- Z Nasdaq
- NBIX Nasdaq
- Market Cap
- Z 14.7B
- NBIX 12.0B
- IPO Year
- Z 2011
- NBIX 1996
- Fundamental
- Price
- Z $68.36
- NBIX $124.56
- Analyst Decision
- Z Buy
- NBIX Strong Buy
- Analyst Count
- Z 27
- NBIX 20
- Target Price
- Z $81.32
- NBIX $163.20
- AVG Volume (30 Days)
- Z 2.4M
- NBIX 1.6M
- Earning Date
- Z 05-07-2025
- NBIX 07-31-2025
- Dividend Yield
- Z N/A
- NBIX N/A
- EPS Growth
- Z N/A
- NBIX N/A
- EPS
- Z N/A
- NBIX 2.96
- Revenue
- Z $2,305,000,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- Z $16.68
- NBIX $15.99
- Revenue Next Year
- Z $14.99
- NBIX $14.93
- P/E Ratio
- Z N/A
- NBIX $41.97
- Revenue Growth
- Z 14.96
- NBIX 21.73
- 52 Week Low
- Z $40.61
- NBIX $84.23
- 52 Week High
- Z $89.39
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- Z 53.81
- NBIX 65.13
- Support Level
- Z $64.19
- NBIX $121.42
- Resistance Level
- Z $68.09
- NBIX $125.63
- Average True Range (ATR)
- Z 1.73
- NBIX 2.85
- MACD
- Z 0.01
- NBIX -0.01
- Stochastic Oscillator
- Z 54.23
- NBIX 88.89
About Z Zillow Group Inc. Class C Capital Stock
Zillow Group Inc is an Internet-based real estate company that offers its customers an on-demand experience for selling, buying, renting, or financing with transparency and ease The group works with real estate agents, brokers, builders, property managers, and landlords to pair technology with top-notch service. The group has brands such as Zillow, Trulia, StreetEasy, Hotpads, Zillow Rentals, Zillow Premier Agent and others.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.